Skip to content

WHITEHAWK THERAPEUTICS, INC.: 10-K filed 2012-03-30

What WHITEHAWK THERAPEUTICS, INC. reported in its annual report filed 2012-03-30 (fiscal FY 2011): 15 published measures, 48 facts as tagged in accession 0001144204-12-018750.

This filing

Form
10-K (annual report)
Filed
2012-03-30
Fiscal period
fiscal FY 2011
Accession
0001144204-12-018750 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WHITEHAWK THERAPEUTICS, INC. filings.

Reported measures

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-31-68,176USD
At 2010-12-31-40,991USD
At 2009-12-31-18,596USD
At 2008-12-311,400USD
At 2007-12-3135,023USD
At 2007-11-160USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-12-314,125USD
At 2010-12-3126,898USD
At 2009-12-3111,142USD
At 2007-11-160USD
At 2007-11-150USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-27,185USD365
2007-11-17 to 2011-12-31-118,176USD1506
2010-01-01 to 2010-12-31-22,395USD365
2009-01-01 to 2009-12-31-19,996USD365
2008-01-01 to 2008-12-31-33,623USD366
2007-11-17 to 2007-12-31-14,977USD45

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-22,773USD365
2007-11-17 to 2011-12-31-105,875USD1506
2010-01-01 to 2010-12-31-19,244USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-12-310USD365
2007-11-17 to 2011-12-31110,000USD1506
2010-01-01 to 2010-12-3135,000USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-23,585USD365
2007-11-17 to 2011-12-31-111,852USD1506
2010-01-01 to 2010-12-31-20,509USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-316,625USD
At 2010-12-3129,398USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-01-01 to 2011-12-313,600USD365
2007-11-17 to 2011-12-316,324USD1506
2010-01-01 to 2010-12-311,886USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-3174,801USD
At 2010-12-3170,389USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-12-312,977USD
At 2010-12-312,165USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-315,000,000shares
At 2010-12-315,000,000shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-12-315,500USD
At 2010-12-315,500USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-3123,585USD365
2007-11-17 to 2011-12-3196,209USD1506
2010-01-01 to 2010-12-3120,509USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-12-310USD365
2007-11-17 to 2011-12-3150,000USD1506
2010-01-01 to 2010-12-310USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31812USD365
2007-11-17 to 2011-12-312,977USD1506
2010-01-01 to 2010-12-311,890USD365

Inspect the source

Entity
WHITEHAWK THERAPEUTICS, INC. / CIK 0001422142
Captured
2026-09-20T08:03:20.803Z
SEC response SHA-256
0bc3518b433577b57088b38c087953d494e28bdd319b1da3b435ea8e7e18b0c1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001422142.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))